Loss of MCL1 function sensitizes the MDA‐MB‐231 breast cancer cells to rh‐TRAIL by increasing DR4 levels
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Loss of MCL1 function sensitizes the MDA‐MB‐231 breast cancer cells to rh‐TRAIL by increasing DR4 levels
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-03-26
DOI
10.1002/jcp.28479
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mcl-1 targeting could be an intriguing perspective to cure cancer
- (2018) Anna De Blasio et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Triple negative breast cancer: the kiss of death
- (2017) Adriana-Andreea Jitariu et al. Oncotarget
- Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation
- (2017) Rosa Drago-Ferrante et al. Oncotarget
- Onto better TRAILs for cancer treatment
- (2016) D de Miguel et al. CELL DEATH AND DIFFERENTIATION
- Unusual roles of caspase-8 in triple-negative breast cancer cell line MDA-MB-231
- (2016) ANNA DE BLASIO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The analysis of estrogen receptor-α positive breast cancer stem-like cells unveils a high expression of the serpin proteinase inhibitor PI-9: Possible regulatory mechanisms
- (2016) MARIANNA LAURICELLA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Parthenolide and DMAPT exert cytotoxic effects on breast cancer stem-like cells by inducing oxidative stress, mitochondrial dysfunction and necrosis
- (2016) D Carlisi et al. Cell Death & Disease
- Sorafenib Inhibition of Mcl-1 Accelerates ATRA-Induced Apoptosis in Differentiation-Responsive AML Cells
- (2015) R. Wang et al. CLINICAL CANCER RESEARCH
- Caspase-8 activation by TRAIL monotherapy predicts responses to IAPi and TRAIL combination treatment in breast cancer cell lines
- (2015) R Polanski et al. Cell Death & Disease
- The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics
- (2015) A. N. Hata et al. Cancer Discovery
- Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells
- (2015) Rachana Trivedi et al. Frontiers in Oncology
- Three-Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell-Based Biosensors
- (2014) Rasheena Edmondson et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- MicroRNA-29b-1 impairs in vitro cell proliferation, self-renewal and chemoresistance of human osteosarcoma 3AB-OS cancer stem cells
- (2014) RICCARDO DI FIORE et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Heterogeneity in breast cancer
- (2011) Kornelia Polyak JOURNAL OF CLINICAL INVESTIGATION
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- Triple-Negative Breast Cancer: An Unmet Medical Need
- (2011) C. A. Hudis et al. ONCOLOGIST
- Bcl-2 expression and triple negative profile in breast carcinoma
- (2010) Imen Kallel-Bayoudh et al. MEDICAL ONCOLOGY
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- New insights into apoptosis signaling by Apo2L/TRAIL
- (2010) F Gonzalvez et al. ONCOGENE
- Looking ahead in cancer stem cell research
- (2009) John E Dick NATURE BIOTECHNOLOGY
- Mcl-1: A Gateway to TRAIL Sensitization
- (2008) S.-H. Kim et al. CANCER RESEARCH
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search